The apical ectodermal ridge (AER) is a critical signaling center at the tip of the limb that promotes outgrowth. In mouse, formation of the AER involves a gradual restriction of AER gene expression from a broad ventral preAER domain to the tip of the limb, as well as progressive thickening of cells to form a multilayered epithelium. The AER is visible from embryonic day 10.5 to 13.5 (E10.5-E13.5) in the mouse forelimb. Previous short-term fate mapping studies indicated that, once a cell is incorporated into the AER, its descendents remain within the AER. In addition, some preAER cells appear to become incorporated into the ventral ectoderm. In the present study, we used an inducible CreER/loxP fate mapping approach in mouse to examine the long-term contribution of preAER cells to limb ventral ectoderm, as well as the ultimate fate of the mature AER cells. We used a CreER transgene that contains Msx2 regulatory sequences specific to the developing AER, and demonstrate by marking preAER cells that, at stage 2 of mouse limb bud development, the majority of the ventral ectoderm that protrudes from the body wall later covers only the paw. Furthermore, when Msx2-CreER-expressing preAER cells are marked after the onset of preAER gene expression, a similar domain of paw ventral ectoderm is marked at E16.5, in addition to the AER. Strikingly, mapping the long-term fate of cells that form the mature AER showed that, although this structure is indeed a distinct compartment, AER-derived cells are gradually lost after E12.5 and no cells remain by birth. A distinct dorsal/ventral boarder nevertheless is maintained in the ectoderm of the paw, with the distal-most border being located at the edge of the nail bed. These studies have uncovered new aspects of the cellular mechanisms involved in AER formation and in partitioning the ventral ectoderm in mouse limb.
Introduction
The limb has been used as a model system to explore the underlying cellular and genetic mechanisms that regulate organ patterning in vertebrates for many decades (reviewed in Martin, 1998; Tickle and Munsterberg, 2001) . Patterning and growth of the limb is regulated by two distinct organzing centers and factors expressed in the dorsal and ventral ectoderm. One organizer, the apical ectodermal ridge (AER), is located at the tip of the limb and regulates out-growth, whereas the zone of polarizing activity (ZPA) in the posterior mesenchyme regulates anterior/posterior (A/P) patterning. The ectoderm in turn regulates dorsal/ventral (D/V) patterning. The AER forms at the tip of the limb bud in mouse about 24 h after the limb bud is first apparent, and can be distinguished as a multilayered epithelium. Genes such as Fgf8 and Msx2 that are expressed in the mature AER are first expressed in a broad domain of ventral ectoderm and then progressively become restricted to the AER at the tip. The transient ventral ectoderm domain defined by Fgf8 and Msx2 expression also forms a thickened ectoderm (Milaire, 1974) and has been called the preAER (Loomis et al., 1998) . Like the changes in AER gene expression, the ventral thickened ectoderm progressively becomes restricted to the limb bud tip, suggesting that cell movement might act to restrict the preAER cells to the tip. By embryonic day 13.5 (E13.5) in the mouse, the AER is no longer visible as a morphological structure, and expression of most AER genes is extinguished.
A number of studies have indicated that the AER becomes a distinct developmental compartment; however, the long-term fate of the AER is not known. Chick-quail transplantation studies have indicated that, once the cells of the stratified AER are apparent, the cells have an inherent property to self organize (Saunders et al., 1976) . When AER cells are removed, trypsinized, and transplanted to either the dorsal or ventral ectoderm, they induce growth of partial secondary limbs. Furthermore, the new AER that forms at the tip of the secondary outgrowths is made up solely of donor cells, although a few donor cells can contribute to the adjacent ectoderm 52 h after transplantation. These studies suggested that the AER is a self-sustaining cell population that induces outgrowth of surrounding tissue. Short-term fate mapping studies of the ectoderm that gives rise to the AER in chick embryos demonstrated that once a cell is incorporated into the AER, it becomes restricted to the AER. One study indicated that cells do not become committed to an AER fate until after HH13-16 (Hamburger and Hamilton, 1951) . Of 104 groups of ectoderm cells marked with dye at HH13-16, only 3 contained cells restricted to the AER 48 h later, whereas 55 groups of cells contained marked cells in the dorsal or ventral ectoderm, in addition to the AER (Altabef, 1997) . The cells within the AER, however, spread out along the A/P axis of the AER, forming a cohesive unit. Of significance, no groups of cells marked both dorsal and ventral ectoderm. Using quail to chick homotypic transplantation of small domains of ectoderm and mesoderm at HH13 (ϳ20 somite stage), a region with its midpoint at the lateral border of the Wolffian duct was found to primarily contribute to the AER and limb mesoderm 40 -44 h later (Michaud et al., 1997) .
A limitation of the chick studies was that the fate of single cells was not analyzed. To determine the fate of individual limb ectodermal cells in mouse, we performed a clonal analysis by marking cells with a retrovirus at E8.5 (5-10 somites). Analysis of clones with cells in the AER 3-4 days later demonstrated that the majority of cells (18/ 22) are restricted to an AER fate by this early stage in mouse (Kimmel et al., 2000) . Furthermore, at E10.5, all but one of the AER clones was restricted to the dorsal or ventral AER. One day later, the dorsal and ventral cells mix within the AER, but do not contribute to non-AER ectoderm. Together, the studies in mouse and chick demonstrate that there are cells within the ectoderm that can initially contribute to both the AER and non-AER ectoderm, but later they become restricted to the AER, for at least 3 days.
The genetic mechanism that regulates formation of the AER is not fully understood. In chick, gain-of-function studies have shown that a Wnt factor (likely Wnt3a) is likely involved in inducing Fgf8 and the AER (Kenagaku et al., 1998; Kawakami et al., 2001) . In mouse, Wnt/␤-catenin signaling is also necessary and sufficient for AER induction, and Wnt3 is critical for this process (Galceran et al., 1999; Barrow et al., 2003) . Furthermore, Wnt signaling in chick and mouse regulates the initiation of D/V patterning by inducing En1 in the ventral ectoderm. Bmp molecules also regulate D/V patterning and AER formation through induction of En1 and Fgf8 expression (Ahn et al., 2001; Pizette et al., 2001) . We have shown that the transcription factor En1 plays a later role in the morphological changes required to form a tight multilayered epithelium at the tip of the limb bud (Loomis et al., 1996) . In En1 mutants, the AER remains as a broad thickened ectoderm that expresses the known AER genes. Associated with this phenotype, the dorsal factor Wnt7a (Riddle et al., 1995; Parr and McMahon, 1995) becomes misexpressed in the ventral ectoderm, and removal of Wnt7a in En1 mutants rescues the abnormal AER morphology (Cygan et al., 1998; Loomis et al., 1998) . One possibility is that the ectopic expression of Wnt7a in the ventral ectoderm inhibits the preAER cells in En1 mutants from constricting into a narrow AER at the limb tip.
In order to follow the development of defined groups of cells in the mouse embryo, we developed a new Cre/loxP based fate mapping approach that initially marks cells based on the expression pattern of Cre at particular times during development (Kimmel et al., 2000; Zervas et al., unpublished observations) . The technique involves expressing an inducible form of Cre recombinase (CreER) that is fused to an altered estrogen binding domain from a tissue-specific (Feil et al., 1996) , or gene-specific, promoter/enhancer (see Fig. 1 ). Mice carrying such a transgene are bred with mice carrying a reporter allele such as R26R (Soriano, 1999) that contains a loxP-STOP-loxP-LacZ cassette expressed from the ubiquitous ROSA locus, to identify and follow cells expressing active CreER. Upon injection of tamoxifen into the mice, the CreER becomes transiently functional by translocation into the nucleus. The STOP signal in the reporter allele is then deleted, Fig. 1 . Fate mapping approach using inducible Msx2-CreER transgenic mice and R26R reporter mice. (A) Transgenic mice carrying CreER expressed from an Msx2 enhancer and promoter (Msx2 enh/P) in the preAER and AER, and the R26R reporter allele that has the potential to express lacZ ubiquitously following Cre activity, are injected with tamoxifen to transiently activate CreER within 6 h for approximately 24 h. CreER protein (red dots) translocates to the nucleus and becomes active. The STOP sequence in the R26R locus is deleted and lacZ is then expressed permanently in preAER or AER cells and all their progeny. (B) The starting population (left side of arrow) of preAER (top) or AER (bottom) cells marked by transient CreER activity are identified 36 -48 h after tamoxifen injection by X-gal staining for lacZ (shown in blue). The fate of the cells is then determined (right side of arrow) at different time points. Left drawing is a saggital section through a limb and right two drawings are ventral views. (C) Section RNA in situ of an E10.5 Msx2-CreER T transgenic embryo hindlimb using probes for the transcripts indicated. Low (left two panels) and high power (right two panels) photos are shown of sections that are 25 m apart. Msx2-CreER T expression is scattered, but in the same domain as Fgf8 expression. d, dorsal; v, ventral. Magnification bar is equal to 50 m. and the cells and their progeny are permanently marked with lacZ expression. Analysis of mice for lacZ expression 36 -48 h after tamoxifen injection identifies the initial group of cells for the fate map study.
In order to mark the AER, we chose to use an Msx2 promoter/enhancer fragment to express CreER T (Feil et al., 1996) that was previously shown to drive transgene expression at E9.5 in the ventral ectoderm in a similar domain to the preAER and at E10.5-E12 in the AER (Liu et al., 1994) . We then analyzed the short-term fate of Msx2-expressing cells in Msx2-CreER T transgenic embryos (Kimmel et al., 2000) . Injection of tamoxifen at an early stage (E9.5) when Msx2-CreER T is expressed in the preAER results in marking an initial population of scattered cells in the ventral ectoderm, in addition to most of the AER 48 h later. In contrast, tamoxifen injection at E10.5 leads to marking of only the forelimb AER 36 -48 h later. As expected, at either stage, no ventral ectoderm or AER marked cells were found to cross into the dorsal ectoderm. These studies provided further evidence that the AER is a unique compartment and indicate that at least some of the preAER cells do not move to the distal tip of the limb and form the AER. Furthermore, this CreER/loxP fate mapping approach provides a method to study the long-term fate of the AER, as well as the preAER ventral ectoderm cells that do not contribute to the AER.
In this study, we have used Msx-2-CreER T ;R26R mice to determine the fate of preAER cells marked at different stages and the ultimate fate of the AER. An important question was whether the AER persists into the adult, and if so whether it contributes to adult stem cell populations such as those in the nail or epidermis. By injecting tamoxifen at different times during preAER maturation, we found that the Msx2-expressing cells contribute primarily to the distal limb ectoderm of the paw. By analyzing the fate of preAER cells in En1 mutants, we show that preAER cells lacking En1 contribute to the distal tip and ventral ectoderm in a similar manner to normal cells, although the AER domain is broader than normal. To determine the long-term fate of the mature AER, we marked forelimb AER cells at E11 and remarkably found that no marked cells remain by birth. During late gestation, the AER cells are first lost in the interdigit regions and then throughout the limb tip. Finally, by determining the position of the distal-most preAER cells that do not contribute to the AER, we mapped the postnatal D/V border in the postnatal limb to the junction between the hyponychium and nail bed. Our studies provide new insights into the morphogensis and fate of the AER and distal limb ventral ectoderm.
Materials and methods
Breeding and genotyping ROSA-loxP-STOP-loxP-LacZ (R26R) mice were generously provided by Dr. P. Soriano (Soriano 1999) . Both
Msx2-CreER T (Kimmel et al., 2000) and R26R ϩ/Ϫ mice were maintained on an outbred background. Msx2-CreER T transgenic males were bred with R26R females to obtain Msx2-CreER T /ϩ; R26R/ϩ mice, which were then backcrossed to R26R/ϩ mice to generate Msx2-CreER T /ϩ; R26R/R26R males. The Msx2-CreER T /ϩ; R26R/R26R males were used as studs to mate with Swiss Webster (Taconic, 5-6 weeks of age) outbred female mice. Noon of the day when a vaginal plug was detected is designated as E0.5. Limb staging is based on Wanek et al. (1989) and modified by Loomis et al. (1998) . The genotypes of mice were determined by PCR of tail DNA as previously described. The oligos used to genotype Msx2-CreER T mice were: CreER31 (5Ј-CACTTTGATCCACCTGATGG-3Ј) and LacZ tag (5Ј-TACCACAGCGGATGGTTCGG-3Ј), which amplify a DNA fragment of 350 bp (Kimmel et al. 2000) . To genotype the R26R mice three oligos were used: 5Ј-AAAGTCGCTCT-GAGTTGTTAT-3Ј, 5Ј-GCGAAGAGTTTGTCCTCAACC-3Ј, and 5Ј-GGAGCGGGAGAAATGGATATG-3Ј, which amplify an approximately 500-bp wild type and 250-bp mutant fragment (Soriano 1999) . Five or 7.5 mg of tamoxifen per 30 gm female was administered as described previously (Kimmel et al., 2000) or using oral gavage on E8.5 and E9.5 or E10.5 to label the preAER or AER cells, respectively.
Histology and X-gal staining and RNA expression analysis
Embryos or newborns were dissected in PBS and fixed in 4% paraformaldehyde (PFA) at 4°C for 20 min. ␤-Galactosidase activity was detected by X-gal staining according to procedures as described (Kimmel et al., 2000) with the addition of 0.04% deoxycholate in the staining and wash solutions. X-Gal-stained embryos were postfixed with 4% PFA at 4°C for more than 1 h, embedded in OCT, and frozen sections were cut by using a cryostat at a thickness of 12 m. Sections were counterstained with 0.005% Fast Red (Polyscientific, s248). For P0 animals, the limbs were removed and the dorsal sides of the limb were cut open toward the tip of the digits for better penetration. For P8 and P16 animals, the limbs were removed and fixed in 4% PFA for 20 min and frozen cryostat sections prepared. The sections were then postfixed in 4% PFA for 5 min before X-gal staining. As a negative control, 11 E17.5 embryos from mating a Msx2-CreER T /ϩ; R26R/R26R male with a SW female were stained with X-gal, and no blue cells were seen in any embryos. Whole-mount (Kimmel et al., 2000) and section in situs (Wassarman et al., 1997) were performed as previously described with Fgf8 and lacZ tag probes described within.
Results

PreAER cells contribute to distal ventral ectoderm and the AER
In order to determine whether the cells in the preAER contribute to a stable population of ventral ectoderm cells, we utilized our CreER fate mapping approach (Kimmel et al., 2000; Zervas et al., unpublished observations) to mark ventral ectoderm cells of the preAER cells in the limb at different time points and follow their fate until E16.5 (Fig.  1) . The Msx2-CreER T transgenic mouse line (Kimmel et al., 2000) carries an enhancer element from the Msx2 gene (Liu et al., 1994) that expresses an inducible form of Cre (Feil et al., 1996) specifically in limb ectoderm of the preAER and AER. These mice were bred with ROSA-loxP-STOP-loxP-LacZ reporter mice (R26R) (Soriano, 1999) to allow permanent marking of cells that had transiently expressed functional Cre. We and others have shown that such an inducible CreER protein begins to be translocated into the nucleus within 6 h of injection of tamoxifen and is then active for approximately 30 h (Kimmel et al., 2000; Hayashi and McMahon, 2002; Zervas et al., unpublished observations) . In addition, ␤-galactosidase can be detected 24 -36 h posttamoxifen injection in Msx2-CreER T ;R26R mice (Kimmel et al., 2000) .
The Msx2-CreER T transgene we used is first expressed in the preAER at limb stage 1 (see Fig. 3 in Kimmel et al., 2000) , or E9.5 in the forelimb and 12 h later in the hindlimb. To further characterize the expression of the transgene and determine the stage of AER maturation at the times when tamoxifen was injected, we sectioned the limbs of E9.5 and E10.5 Msx2-CreER T transgenic embryos. In embryos taken at 11 am on E10.5, the forelimb was at stage 3 to 3.5 with a distally contracted preAER, whereas the hindlimbs were at stage 1.5 to 3 with a broader and less mature preAER (Fig.  1C , and data not shown). We analyzed adjacent sections of embryos at the later stage for transgene expression and compared it with expression of another preAER gene, Fgf8. Transgene and Fgf8 expression in the later stage embryos was restricted to the morphologically distinct preAER (Fig.  1C , and data not shown). Transgene expression was in scattered cells, whereas Fgf8 expression was homogeneous and also stronger since it could be detected after a shorter period of staining. In embryos taken at 4 pm on E9.5, the forelimbs were at stage 1 to 1.5, and the preAER was clearly visible morphologically as a thickened ectoderm in the ventral distal limb, whereas the hindlimb was just beginning to form. Transgene expression was throughout the forelimb preAER in a slightly broader domain than Fgf8 (data not shown).
Our previous short-term analysis of Msx2-CreER T ;R26R embryos injected with tamoxifen in the morning of E9.5 showed lacZ marking of scattered cells in the distal ventral ectoderm at E11.5, as well as more homogeneous staining of the AER 36 -48 h later. To determine the long-term fate of the ventral ectoderm cells derived from the Msx2-CreER T -expressing preAER cells at the stage the Msx2 enhancer is first expressed, we injected Msx2-CreER T ;R26R embryos with tamoxifen on day E8.5 at 9 am or 4 -5 pm and day E9.5 at 9 am and then analyzed for ␤-galactosidase staining at later stages (Table 1) . Embryos were analyzed 44 -48 h (Fig. 2C inset, N, P; and data not shown) or 65-72 h ( Fig. 2A-D; and data not shown) after injection to determine the starting population of cells that was marked by tamoxifen-induced CreER activity. In all cases, the initial population of marked cells spanned a similar region, although not all cells within this region were marked due to mosaic expression of the transgene. Embryos were then analyzed at E12.5 ( Fig. 2E-H; and data not shown) and E16.5 ( Fig. 2I -L, M, O; and data not shown) to determine the fate of the preAER cells that did not incorporate into the AER but resided in the ventral ectoderm at E11.5. The results were similar for all three injection times.
Embryos analyzed 44 h after tamoxifen injection at 4 -5 pm on E8.5 (E10.5) showed lacZ staining in scattered cells in the distal ventral ectoderm, as well as in the AER (n ϭ 4 embryos) (Fig. 2C inset; and data not shown). The domain of ventral ectoderm that expressed lacZ appeared broader in the more immature hindlimb than in the forelimb, such that in the hindlimb the cells marked all but the most proximal region of the ventral ectoderm. Importantly, no cells were marked in the dorsal ectoderm. At E11.5, the paw plate is visible as an enlarged oval in the distal portion of the limb circumscribed by the AER. Following tamoxifen injection at the three time points, lacZ was expressed extensively in the AER at E11.5, as well as in scattered cells throughout the ventral paw plate (i.e., the cells surrounded by the AER) ( Fig. 2A -D, N, P; and data not shown). At E12.5, the marked ventral ectoderm cells in Msx2-CreER T ;R26R embryos injected with tamoxifen at 4 pm on day E8.5 were also restricted to the paw plate (n ϭ 12 embryos) ( Fig. 2E and  G) . Section analysis demonstrated that the marked cells were confined to the ventral ectoderm and AER, and did not extend into the dorsal ectoderm ( Fig. 2F and H) . At E16.5, when the fore-and hind-paws are well delineated from the more proximal limb regions, the lacZ-marked cells remained primarily restricted to the ventral paw (n ϭ 7 embryos) ( Fig. 2I and K) in a relatively random pattern of marked cells, or groups of cells. In contrast, along the zeugopod of all the limbs, there were one or more line(s) of marked cells extending from the paw along the ventral leg or arm, suggesting a different form of cell mixing in the paw and zeugopod. In the majority of cases, the lines were along either side of the ventral limb. One possibility is that the cells streamed proximal from the AER, as has been described in chick (Altabef et al., 1997) . Alternatively, the cells may stream from the paw ventral ectoderm that is marked. Although at E16.5 the AER is no longer visible as a morphological structure in sections, the distal border of marked cells maintained a sharp boundary at the tip of the limb ( Fig. 2J and L; and data not shown). Similar results were obtained when tamoxifen was injected at 9 am on E8.5 (n ϭ 5) (data not shown) or E9.5 (n ϭ 7) ( Fig. 2M and O) . These data demonstrate that, at E10.5, most of the ventral ectoderm that protrudes from the body wall in the hindlimb (stage 2) gives rise to the AER and ectoderm that covers the paw, and not more proximal limb structures. We were next interested in whether the preAER consists of the same group of cells at different stages of maturation, or becomes a more distally restricted group of cells. To test this question, tamoxifen was injected at 4 pm on E9.5 (n ϭ 10) and 9:00 am on E10.5 (n ϭ 4). Based on our section analysis, CreER T expression in the forelimbs is restricted to the tip by the morning of E10.5 in a distally contracted small preAER (Fig. 1C) . Thus, injection at 4 pm on E9.5 should mark the contracting preAER 6 to 37 h later, and injections in the morning of E10.5 should primarily mark a mature AER structure. In the hindlimb, AER maturation was found to be delayed by approximately 12 h. In the hindlimbs at E16.5 of embryos injected at both time points, the staining was similar to the staining seen when tamoxifen was injected at earlier stages ( Fig. 2R and S) . The forelimb also showed similar staining in 7/10 CreER T ;R26R embryos injected at 4 pm on E9.5 (Fig. 2Q ). However, in 3 embryos, the staining was restricted to the ventral digits at E16.5 (Fig.  2Q inset) . In addition, all the forelimbs had fewer lines of Fig. 3 . PreAER cells in En1 mutants remain restricted ventrally and contribute to non-AER ectoderm, as well as to the expanded AER. Tamoxifen was injected at 4 -5:00 pm on E8.5, and embryos were stained for lacZ expression at E11.5 (A-F) or E12.5 (G-J). The limbs were photographed on end (A-F) or from the ventral side (G-J). (C, F) The limbs were double labeled for lacZ (turquoise) and Fgf8 mRNA expression (purple). The Fgf8 expression obscures most of the lacZ expression. (I) The En1 mutant limb has an ectopic ventral digit (arrow). Inset shows side view. PreAER cells (blue) can be seen to contribute mainly to the ectopic AER at the tip of the digit. In En1 mutants, the preAER (blue) cells do not form a tight narrow band at the tip of the limb, but form a broader more diffuse band at the tip. Marked cells also contribute to the ventral non-AER ectoderm. d, dorsal; v, ventral; FL, forelimb; FL/V forelimb ventral; HL, hindlimb; HL/V, hindlimb ventral. Fig. 4 . The AER is a transient structure that is lost by birth. Tamoxifen was injected at 4 -5:00 pm on E10.5, and embryos or limbs were stained for lacZ expression at different embryonic days or postnatal day 0 (P0) as indicated. All limbs are shown from the ventral side. Arrows indicate marked cells in the ventral ectoderm. No staining was seen on the dorsal side of the limb. (C, D, I, J) Sections of stained limbs illustrating lacZ marking primarily restricted to the AER (C, D) or distal tip (I, J). A few groups of non-AER-marked ventral ectoderm cells were consistently seen in the hindlimb and are indicated by arrows. Examples of the small number of ventral marked cells (arrows) found in some forelimbs are shown in (E), and the inset to (I). The light blue in the ventral ectoderm of the forelimb shown in (K) (asterisks) is nonspecific staining. The insets in (K) and (L) show a higher magnification view of typical single marked cell or group of cells at the tip of the digits of some forelimbs or hindlimbs, respectively. d, dorsal; v, ventral; FL, forelimb; FL/V forelimb ventral; HL, hindlimb; HL/V, hindlimb ventral. Magnification bar is equal to 50 m. marked cells along the ventral forearm than at earlier stages of tamoxifen injection. Consistent with formation of an AER in the forelimb by E10.5, CreER T ;R26R embryos at E16.5 that had been injected with tamoxifen at 9 am on E10.5 showed staining restricted to the tips of the limbs (Fig. 2T ). Taken together, these studies indicate that Msx2expressing preAER cells remain as a constant population of cells that contribute to the ventral ectoderm until the AER is nearly formed (ϳstage 3.5).
PreAER in En1 mutants contributes to the ventral ectoderm in addition to the AER
In mice lacking the ventral gene En1, the AER is much broader than in normal animals by E11.5. One possible explanation for this is that, in the absence of En1 in ventral ectoderm cells, the preAER cells do not extinguish AER marker gene expression and all these cells form the broad AER (Loomis at el., 1998) . To determine whether this is the case, we bred the Msx2-CreER T and R26R transgenes onto an En1 mutant background. Mothers carrying the embryos were injected with tamoxifen at 4:00-5:00 pm on E8.5 and analyzed for ␤-galactosidase activity on E11.5. When ␤-galactosidase staining of the limbs of CreER T /ϩ;R26R/ϩ; En1 Ϫ/Ϫ mutant embryos (n ϭ 12) was observed from the ventral side, the pattern was similar to normal embryos ( Fig.  3B and E) with near homogeneous staining at the tip and scattered staining in the ventral ectoderm cells circumscribed by the AER. The staining at the tip, however, was clearly broader in the En1 mutant embryos than in normal embryos, as seen better in views of the limb tips (compare Fig. 3A and 3D) . Scattered lacZ marked cells were found in the expanded part of the AER (identified in some cases by costaining for Fgf8 expression; n ϭ 3 embryos), as well as in the adjacent non-AER ventral ectoderm ( Fig. 3C and F) . No marked cells were found in the dorsal ectoderm. The results were similar in E12.5 CreER T /ϩ;R26R/ϩ;En1 Ϫ/Ϫ mutant embryo limbs (n ϭ 2) ( Fig. 3G-J) . In cases in which an ectopic digit was induced (Fig. 3I) , the ectoderm of the digit was primarily made up of cells not stained with lacZ, although dense blue cells were seen at the tip, suggesting the preAER cells preferentially form the ectopic AER. Thus, the expanded AER and ectopic digits in En1 mutants are not formed exclusively by inclusion of all preAER cells in these structures. Furthermore, although En1 acts like a selector gene for ventral skin appendage development, it is not necessary for pre-AER cells to contribute to the non-AER ventral ectoderm.
The AER is a transient structure
In order to determine the ultimate fate of cells within the AER, Msx2-CreER T ;R26R mice were injected with tamoxifen at 4 -5 pm on E10.5 and assessed at E12.5 to determine the initial population of marked cells and then analyzed at later stages (E14.5, 16.5, postnatal day 0; P0) to follow the fate of cells marked in the AER. In the forelimb at E12.5, only scattered marking of the AER was detectable (n ϭ 5 embryos) (Fig. 4A) . In sections, the staining appeared restricted to the AER (Fig. 4C ). In the hindlimb (n ϭ 5 embryos) at E12.5, in addition to near homogeneous staining in the AER (Fig. 4B) , a few ventral ectoderm cells adjacent to the AER were marked (arrows in Fig. 4B) , consistent with maturation of the hindlimb being delayed and expression of Msx2-CreER in the distal most ventral ectoderm of the preAER at E10.5. These non-AER ventral ectoderm cells could be seen most clearly in sections (arrows in Fig. 4D ).
Since in Msx2-CreER T ;R26R mice injected with tamoxifen on E10.5 only the AER cells are marked in the forelimb, we used these animals to map the fate of the AER. Whereas at E12.5, marking of the AER was continuous along the A/P axis, at E14.5, the forelimb marking was discontinuous and patchy, with less (or no) marking between the forming digits (n ϭ 9 embryos) (Fig. 4E) . The occasional small group of marked cells was seen in the distal ventral ectoderm. At E16.5, only scattered cells primarily at the tips of the forelimb digits were marked (n ϭ 6 embryos) ( Fig. 4G ) and in sections no obvious morphological structure like an AER could be seen (Fig. 4I ). In 6 out of 12 forelimbs at E16.5, there were a few scattered cells marked in the ventral ectoderm (arrows in Fig. 4G and inset in 4I). Strikingly, at P0, no groups of marked cells were detected at the tip of the forelimb (Fig. 4K ). In 6 out of 50 forelimb digits, a single marked cell was seen in the distal ventral ectoderm (inset in Fig. 4K ). The few remaining ventral marked groups of cells in 3 out of 10 limbs were in the distal-most part of the digits (data not shown and see below). These studies demonstrate that the AER is only a transient structure and that it does not contribute significantly to the postnatal limb in mouse. This result also shows that the streams of cells along the zeugopod seen with marking of Msx2-CreER T cells at preAER stages must come from the ventral ectoderm marked cells, and not the AER.
Analysis of the tips of the hindlimbs of Msx2-CreER T ; R26R embryos injected with tamoxifen on E10.5 revealed similar results in the AER to those in the forelimb. At E14.5, the staining was more homogeneous at the tip of the hindlimb (n ϭ 9 embryos) than in the forelimb, and all limbs had staining on the digits (Fig. 4F) . At E16.5, the staining was mainly at the tips and on the ventrolateral edges of the digits in all (n ϭ 12) limbs ( Fig. 4H and J) . At P0, 2 out of 10 hindlimbs had no staining at the tips or along the ventral ectoderm of the digits. In 9 out of 50 digits, a single marked cell was seen in the distal ventral ectoderm, similar to what was observed in the forelimbs. In 5 out of 10 limbs, one or more groups of cells were marked on the ventral digits or paw (arrow in Fig. 4L and inset) , consistent with the marking of cells adjacent to the AER at earlier stages.
A distal dorsal/ventral border remains after birth in the limb ectoderm
Since our analysis of the forelimbs and hindlimbs showed that at P0 the AER cells are lost, we marked pre-AER cells at E8.5 to identify the position of the distal most ventral ectoderm after birth. Whole-mount staining of limbs at P0 (n ϭ 4 embryos) revealed that the preAER-marked cells remain in the ventral ectoderm with a sharp border near the digit tips ( Fig. 5A and B) . Sections of the limbs at P0 (n ϭ 2 limbs), P8 (n ϭ 2 limbs), and P16 (n ϭ 2 limbs) (data not shown and Fig. 5C and D) showed that the D/V border, as determined by the distal-most marked ventral ectoderm cells, was at the distal edge of the hyponychium, bordering the nail bed. The marked cells were incorporated into all layers of the epidermis, as well as all ectodermal components of eccrine glands and hair follicles ( Fig. 5E , and data not shown), on the proximal ventral limbs. Our analysis of preAER cells in Msx2-CreER T ;R26R embryos shows that after birth there is still a sharp D/V border at the edge of the distal limb ectoderm within the nail unit. In addition, no ventral ectoderm marked cells cross into the dorsal ectoderm along the edges of the paw or more proximal limb regions.
Discussion
The AER is a source of growth factors that are essential for limb outgrowth (reviewed in Martin, 1998; Tickle and Munsterberg, 2001) . Removal of the chick AER at progressively earlier stages of development results in more severe truncations of distal limb elements, indicating that limb development proceeds in a proximal-to-distal manner (Saunders, 1948; Summerbell, 1974) . A recent study showed that the defects in limb outgrowth after AER removal correlate with death of the underlying mesenchyme cells of the progress zone (Dudley et al., 2002) . Insertion of beads soaked with Fgfs into the limb tip can rescue the limb truncations caused by AER removal, and four Fgfs (4, 8, 9, 17) are expressed in the AER (Martin, 1998) . Nevertheless, only Fgf8 has been found to be essential for mouse limb outgrowth Sun et al., 2000; Lewandowski et al., 2000; Xu et al., 200) , although Fgf4 and Fgf8 collaborate in maintaining outgrowth (Sun et al., 2002) . Much of the function of the Fgfs, and the AER, therefore appears to be to maintain proliferation of the limb mesenchyme. While the properties of the AER have been studied extensively, less is known about the cellular and genetic mechanisms that control formation of a multilayered AER from a broad ventral preAER domain, or the long-term fate of AER cells. We have used an inducible Cre fate mapping approach in transgenic mice to show that preAER cells at all stages of maturation contribute to the ventral ectoderm, as well as the AER. Furthermore, the cells are primarily restricted to the paw ventral ectoderm. We also demonstrate that, although the AER is a self-sustaining segregated cell population, all descendents of the AER ultimately die before birth (see Fig. 1B ).
Distal ventral ectoderm is regionally divided along the proximal-distal axis by E9
The fact that some cells of the preAER do not contribute to the mature AER, but instead form distal ectoderm in limb buds by E11.5, allowed us to map the fate of these ventral ectoderm cells. Strikingly, when CreER activity was induced at three early stages to mark the initial preAER population (9:00 am or 4:00 pm on E8.5 and 9:00 am on E9.5) the marked cells primarily contributed to the ventral paw ectoderm at E16.5 and postnatal stages. We found that, in the hindlimb, the initial region of marked cells (E10.5 or stage 2) included all but a narrow row of the most proximal cells of the ventral limb bud. Thus, at stage 1-2 in mouse limb bud development, many cells in the ventral ectoderm that extend from the body wall are destined to cover primarily the paw. Interestingly, at E16.5 or postnatal stages, a small portion of marked cells was found in the more proximal limb, and these formed long thin lines along much of the length of the limb, and often they appeared to extend from groups of cells covering the paw. The extension of cells along the length of the limb was seen in previous fate mapping studies of the chick limb ectoderm (Altabef et al., 1997) . These results show that there is a tendency for the cells of the early paw plate at E11.5 to remain covering the paw, but that some cells and their progeny will proliferate and extend the length of the limb, and even cross into the adjacent body ectoderm (data not shown).
Formation of the AER from the preAER is complex
One model for the mechanism by which preAER cells become restricted to the tip of the limb during AER maturation involves movement of all the preAER cells in the early ventral ectoderm to the tip as they become a multilayered epithelium (Millaire et al., 1974; Michaud et al., 1997; Loomis et al., 1998) . If this is the case, then marking preAER cells at different stages of preAER maturation, by varying the time point of tamoxifen injection, should result in always marking the same ectoderm domain at all successive stages. Indeed, this is what was observed until the latest stage (ϳ3.5) of AER maturation. However, while many lacZ-marked preAER cells were incorporated into the AER at E11.5, by E16.5 the ventral paws were composed of a surprisingly large number of preAER-derived cells. Since we found that when we marked only forelimb AER cells at E10.5 the vast majority of marked cells are lost by E16.5, the cells in the ventral paw must be derived from preAER cells that did not incorporate into the AER. Thus, during late maturation of the preAER to form an AER, many cells (possibly the more proximal cells) revert to a ventral limb ectoderm fate. Furthermore, this must be accompanied by extinction of AER gene expression in such cells.
One possible mechanism to achieve restriction of AER gene expression to the tip would be to have a signal from the dorsal ectoderm, possibly a Wnt molecule, that maintains and reenforces AER gene expression and induces a multilayered epithelial morphology in the adjacent cells. Consistent with this idea, in En1 mutants, Wnt7a is misexpressed in the ventral ectoderm, and as a consequence, the AER is much broader than normal. To determine whether some preAER cells in En1 mutants also contribute to the ventral ectoderm, we analyzed the fate of the preAER in En1 mutants by inducing Cre activity at 4 -5 pm on E8.5. As in wild type limbs at E11.5, not all preAER cells contributed to the broad AER and such cells covered the pawplate. Thus, some cells must turn off AER markers (as mimicked by Msx2-CreER T ) even in the absence of En1 and form ventral ectoderm. Strikingly, in En1 mutants, as in normal embryos, a concentration of preAER cells was found in a band at the tip of the limb, although the band was broader in the mutants likely reflecting the expanded AER.
The AER is only a transient structure One surprising finding of our studies was that the vast majority of the AER cells are not sustained after birth. Instead, they are progressively lost after E12.5, first in the interdigit regions and then at the tip of the digits. Thus, the AER is a self-sustaining cell compartment for only a transient period of embryonic development. Of likely relevance, the cells of the AER begin to degenerate after Fgf expression is normally extinguished. Interestingly, although the stratified epithelial nature of the AER also is lost soon after E12.5, the AER cells nevertheless remain at the tips of the digits until after E16.5, but are gone by birth. Only a very small number of cells from the AER appear to become incorporated into the ventral skin and only in the digit tips. This is unlike the chick, where it was reported that cells at the proximal edges of the AER contribute extensively to the lateral ectoderm of the limb (Vargesson et al., 1997) .
In contrast to the loss of AER cells, the ventral ectoderm cells derived from the preAER become incorporated into the normal ventral skin and skin appendages, and are maintained presumably through incorporation into stem cell populations. Because the preAER cells that do not incorporate into the AER occupy the most distal ventral ectoderm ad- jacent to the AER at all stages, and the AER cells are lost by birth, we were able to determine the ultimate position of the ventral ectoderm of the limb after birth (P8 and 16). Indeed, a sharp D/V ectoderm border at the limb tip is maintained after the AER degenerates. No marked cells cross into the dorsal limb ectoderm, and the D/V border at the tip of the limb after birth is within the nail unit at the junction between the hyponychium and the nail bed. Furthermore, no ventral ectoderm cells in the paw or more proximal limb regions cross into the dorsal ectoderm. Although a clear D/V border could not be identified along the edge of the limb, likely because only scattered cells are marked by our fate mapping procedure, the D/V border appears to be slightly ventral to the midpoint of the D/V axis.
In summary, we have shown that many Msx2-CreER T preAER cells contribute to the ventral ectoderm of the postnatal limb. Furthermore, the majority of such preAER cells contribute to the ventral ectoderm of the distal limb, namely of the paw. Some preAER cells that form the ventral ectoderm do, however, form long lines of cells along the zeugopod. As the preAER matures into an AER from a broad ventral domain to a narrow layer of cells at the distal tip of the limb, some cells extinguish AER marker gene expression and become incorporated into the ventral ectoderm, while the AER appears to form primarily from the more distal cells of the preAER. Finally, the AER is not only a transient morphological structure, but we demonstrate that the cells derived from the mouse AER die by birth.
